Director/PDMR Shareholding

RNS Number : 4357P

GlaxoSmithKline PLC

09 June 2020

 

GlaxoSmithKline plc   (the ' Company ')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Ms S Jackson
b)	Position/status	SVP, Global Communications & CEO Office
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Descriptionofthe financial  instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature ofthe transaction	The sale of 1,209 Ordinary Shares to facilitate a transfer into an ISA.
c)	Price(s)and volume(s)	Price(s) Volume(s) £16.5557 1,209
d)	Aggregated information Aggregated volume Price	N/A (single transaction)
e)	Date ofthe transaction	2020-06-04
f)	Placeofthe transaction	London Stock Exchange ( XLON)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Ms S Jackson
b)	Position/status	SVP, Global Communications & CEO Office
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Descriptionofthe financial  instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature ofthe transaction	The purchase of 1,200 Ordinary Shares into an ISA.
c)	Price(s)and volume(s)	Price(s) Volume(s) £16.5700 1,200
d)	Aggregated information Aggregated volume Price	N/A (single transaction)
e)	Date ofthe transaction	2020-06-04
f)	Placeofthe transaction	London Stock Exchange ( XLON)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr D Jackson
b)	Position/status	PCA of Ms S Jackson (SVP, Global Communications & CEO Office)
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Descriptionofthe financial  instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature ofthe transaction	The sale of 1,209 Ordinary Shares to facilitate a transfer into an ISA.
c)	Price(s)and volume(s)	Price(s) Volume(s) £ 16.5584 1,209
d)	Aggregated information Aggregated volume Price	N/A (single transaction)
e)	Date ofthe transaction	2020-06-04
f)	Placeofthe transaction	London Stock Exchange ( XLON)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr D Jackson
b)	Position/status	PCA of Ms S Jackson (SVP, Global Communications & CEO Office)
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Descriptionofthe financial instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature ofthe transaction	The purchase of 1,201 Ordinary Shares into an ISA.
c)	Price(s)and volume(s)	Price(s) Volume(s) £16.5460 1,201
d)	Aggregated information Aggregated volume Price	N/A (single transaction)
e)	Date ofthe transaction	2020-06-04
f)	Placeofthe transaction	London Stock Exchange ( XLON)

 

END

 

 

DSHXKLFBBQLFBBX